Skip to main content
Brian Wolpin, MD, Oncology, Boston, MA

BrianMWolpinMD

Oncology Boston, MA

Assistant Professor of Medicine, Dana-Farber Cancer Institute

Dr. Wolpin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Wolpin's full profile

Already have an account?

  • Office

    450 Brookine Ave, D1220
    Dana Farber Cancer Institute
    Boston, MA 02215
    Phone+1 617-632-6942
    Fax+1 617-632-5370

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2004 - 2006
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 2001 - 2004
  • Harvard Medical School
    Harvard Medical SchoolClass of 2001

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2003 - 2026
  • NH State Medical License
    NH State Medical License 2024 - 2026
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Diabetes, Weight Change, and Pancreatic Cancer Risk  
    Douglas A Rubinson, Kimmie Ng, Meir J Stampfer, Brian M Wolpin, JAMA Oncology
  • Germline Cancer Susceptibility Gene Variants, Somatic Second Hits, and Survival Outcomes in Patients with Resected Pancreatic Cancer  
    Richard F Dunne, Leona A Doyle, William C Hahn, Jason L Hornick, Andrea J Bullock, Sapna Syngal, Albert C Koong, Natalia Khalaf, Brian M Wolpin, Douglas A Rubinson, Da..., Nature
  • Altered Exocrine Function Can Drive Adipose Wasting in Early Pancreatic Cancer  
    Jared R Mayers, Naoki Takahashi, Nicole Lopez, Brian M Wolpin, Nature

Lectures

  • Performance of a blood-based test for the detection of multiple cancer types. 
    ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020

Authored Content

  • Diabetes, Weight Change, and Pancreatic Cancer RiskAugust 2020
  • Diabetes, Weight Change, and Pancreatic Cancer RiskAugust 2020
  • Diabetes, Weight Change, and Pancreatic Cancer RiskAugust 2020
  • Diabetes, Weight Change, and Pancreatic Cancer RiskAugust 2020
  • Diabetes, Weight Change, and Pancreatic Cancer RiskAugust 2020
  • Join now to see all

Press Mentions

  • Don't Ignore These Pancreatic Cancer Warning Signs
    Don't Ignore These Pancreatic Cancer Warning SignsApril 28th, 2023
  • Novobiocin Attacks BRCA-Mutated Cancer Cells from Within and Without, Study Shows
    Novobiocin Attacks BRCA-Mutated Cancer Cells from Within and Without, Study ShowsMarch 14th, 2023
  • Looking for Early Warning Signs of Pancreatic Cancer
    Looking for Early Warning Signs of Pancreatic CancerMarch 22nd, 2022
  • Join now to see all

Grant Support

  • Cohort Study Of Biochemical And Genetic Risk Factors For Pancreatic CancerNational Cancer Institute2009–2011

Professional Memberships